ArticleJournal of substance abuse treatment2013
Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.
Article in Journal of substance abuse treatment, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 27 citations in OpenAlex.
- The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care.Journal of substance abuse treatment · 2015Trial
- Evaluating and identifying changes in the rate of unplanned discharge among Department of Veterans Affairs (VA) facilities providing substance use disorder residential care.Journal of substance use and addiction treatment · 2024Article
- Medications for Alcohol Use Disorder: Rates and Predictors of Prescription Order and Fill in Outpatient Settings.Journal of general internal medicine · 2024Article
- Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.Addiction science & clinical practice · 2024Article
- The implementation potential of a method to monitor empirically-supported children's mental health treatment through claims data.BMC health services research · 2021Article
- Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care.Journal of general internal medicine · 2021Article
- Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.Contemporary clinical trials · 2021Article
- Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.The American journal of drug and alcohol abuse · 2021Article
- Developing an opioid use disorder treatment cascade: A review of quality measures.Journal of substance abuse treatment · 2018Review
- Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.Journal of substance abuse treatment · 2018Article
- Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.Journal of substance abuse treatment · 2017Article
- Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.PloS one · 2017Article
- Preclinical Medication Development: New Targets and New Drugs.Alcoholism, clinical and experimental research · 2016Review
- Access to Addiction Pharmacotherapy in Private Health Plans.Journal of substance abuse treatment · 2016Article
- The effect of pre-existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center.Cancer medicine · 2015Article
- The Affordable Care Act: an opportunity for improving care for substance use disorders?Psychiatric services (Washington, D.C.) · 2015Review
- Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.Addiction science & clinical practice · 2013Article
- Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders.Journal of addiction medicineArticle
- Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders.Journal of addiction medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
This paper presents the rationale and feasibility of standardized performance measures for use of pharmacotherapy in the treatment of substance use disorders (SUD), an evidence-based practice and critical component of treatment that is often underused. These measures have been developed and specified by the Washington Circle, to measure treatment of alcohol and opioid dependence with FDA-approved prescription medications for use in office-based general health and addiction specialty care. Measures were pilot tested in private health plans, the Veterans Health Administration (VHA), and Medicaid. Testing revealed that use of standardized measures using administrative data for overall use and initiation of SUD pharmacotherapy is feasible and practical. Prevalence of diagnoses and use of pharmacotherapy vary widely across health systems. Pharmacotherapy is generally used in a limited portion of those for whom it might be indicated. An important methodological point is that results are sensitive to specifications, so that standardization is critical to measuring performance across systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.